Diabetes management software from Tandem gets FDA OK

02/28/2013 | San Diego Business Journal

The FDA has cleared Tandem Diabetes Care to market its t:connect diabetes management software. The technology, set to be released next month, provides diabetes patients and their doctors with electronic access to information from the company's t:slim insulin delivery systems and blood glucose monitors.

View Full Article in:

San Diego Business Journal

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ